Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amkay ProductsBOM:544169 37 Buyback Yield % is 0.00 as of Sep. 09, 2026. GuruFocus rates BOM:544169 with a GF Score™ of 37/100. The stock has 2 warning signs investors should review. Among 325 Medical Devices & Instruments companies, Amkay Products ranks worse than 307692% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Amkay Products's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544169 vs ISRG, BDX, RMD: Buyback Yield % Comparison
For the Medical Instruments & Supplies subindustry, Amkay Products's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amkay Products Buyback Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Amkay Products's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Amkay Products's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amkay Products (BOM:544169) has a Buyback Yield % of 0.00 as of Sep. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Amkay Products and its competitors. According to the industry distribution chart, Amkay Products ranks #999999 out of 325 companies in the Medical Devices & Instruments industry.
Is Amkay Products' Buyback Yield % too high?
Amkay Products' current Buyback Yield % is 0.00. Based on the distribution chart, Amkay Products ranks #999999 out of 325 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Amkay Products has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Amkay Products' Buyback Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Amkay Products ranks #999999 out of 325 companies for Buyback Yield %. This places Amkay Products in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Amkay Products and its competitors. Amkay Products's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amkay Products stock overvalued right now?
Amkay Products (BOM:544169) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Amkay Products' overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Amkay Products (BOM:544169), the current Buyback Yield % is 0.00 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amkay Products Ltd is a healthcare company. It manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. Additionally, engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc.
37GF Score
Get the complete analysis for BOM:544169
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544169 has been successfully added to your 
